These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35287671)

  • 1. The monomer TEC of blueberry improves NASH by augmenting tRF-47-mediated autophagy/pyroptosis signaling pathway.
    Zhu J; Wen Y; Zhang Q; Nie F; Cheng M; Zhao X
    J Transl Med; 2022 Mar; 20(1):128. PubMed ID: 35287671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p/ATG2B/PTEN-AKT axis to mediate autophagy and pyroptosis.
    Chen X; Xue W; Zhang J; Peng J; Huang W
    Lipids Health Dis; 2023 Feb; 22(1):22. PubMed ID: 36759837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway.
    Zhu J; Tang W; Wu X; Mu M; Zhang Q; Zhao X
    Biochem Biophys Res Commun; 2024 Aug; 720():150118. PubMed ID: 38776757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MIR22HG/microRNA-9-3p/IGF1 in nonalcoholic steatohepatitis, the ceRNA network increases fibrosis by inhibiting autophagy and promoting pyroptosis.
    Chen X; Zhou S; Chen Y; Tong K; Huang W
    Clin Nutr; 2024 Jan; 43(1):52-64. PubMed ID: 38011754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway.
    Qiu T; Pei P; Yao X; Jiang L; Wei S; Wang Z; Bai J; Yang G; Gao N; Yang L; Qi S; Yan R; Liu X; Sun X
    Cell Death Dis; 2018 Sep; 9(10):946. PubMed ID: 30237538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalin improved hepatic injury of NASH by regulating NRF2/HO-1/NRLP3 pathway.
    Shi H; Qiao F; Lu W; Huang K; Wen Y; Ye L; Chen Y
    Eur J Pharmacol; 2022 Nov; 934():175270. PubMed ID: 36184988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy.
    Zhang N; Wu Y; Zhong W; Xia G; Xia H; Wang L; Wei X; Li Y; Shang H; He H; Lin S
    Phytomedicine; 2022 Jul; 102():154148. PubMed ID: 35576742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T; Zhu J; Zhu L; Cheng M
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blueberry polyphenols play a preventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes.
    Zhuge Q; Zhang Y; Liu B; Wu M
    Ann Palliat Med; 2020 May; 9(3):1045-1054. PubMed ID: 32389004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
    Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
    Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tRNA-derived fragment (tRF-3001b) aggravates the development of nonalcoholic fatty liver disease by inhibiting autophagy.
    Zhu J; Cheng M; Zhao X
    Life Sci; 2020 Sep; 257():118125. PubMed ID: 32702444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of HucMSCs, exosomes, and conditioned medium on NASH.
    Liang C; Gao S; Gao J; Xu Y; Li Q
    Sci Rep; 2023 Oct; 13(1):18431. PubMed ID: 37891247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
    Yu X; Hao M; Liu Y; Ma X; Lin W; Xu Q; Zhou H; Shao N; Kuang H
    Eur J Pharmacol; 2019 Dec; 864():172715. PubMed ID: 31593687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis.
    Ye H; Ma S; Qiu Z; Huang S; Deng G; Li Y; Xu S; Yang M; Shi H; Wu C; Li M; Zhang J; Zhang F; Qin M; Huang H; Zeng Z; Wang M; Chen Y; Lin H; Gao Z; Cai M; Song Y; Gong S; Gao L
    J Ethnopharmacol; 2022 Oct; 296():115457. PubMed ID: 35753609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.
    Koh EH; Yoon JE; Ko MS; Leem J; Yun JY; Hong CH; Cho YK; Lee SE; Jang JE; Baek JY; Yoo HJ; Kim SJ; Sung CO; Lim JS; Jeong WI; Back SH; Baek IJ; Torres S; Solsona-Vilarrasa E; Conde de la Rosa L; Garcia-Ruiz C; Feldstein AE; Fernandez-Checa JC; Lee KU
    Gut; 2021 Oct; 70(10):1954-1964. PubMed ID: 33208407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway.
    Liu Y; Wang DW; Wang D; Duan BH; Kuang HY
    Front Endocrinol (Lausanne); 2021; 12():663039. PubMed ID: 33953700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC; Haczeyni F; Chitturi S
    Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.